Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

In-silico, interactomic and clinical validation based approach for screening and identification of miR biomarkers involved in Oral submucous fibrosis to Oral squamous cell carcinoma transition

View ORCID ProfileShweta Ukey, Jeewan Ram Vishnoi, Chinmayee Choudhury, Purvi Purohit, Shailendra Dwivedi, Ankit jain, Ankita Chugh, Poonam Elhence, Puneet Pareek, Sanjeev Misra, Praveen Sharma
doi: https://doi.org/10.1101/2020.10.05.20206904
Shweta Ukey
aAll India Institute of Medical Sciences, Jodhpur, Rajasthan, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Shweta Ukey
Jeewan Ram Vishnoi
aAll India Institute of Medical Sciences, Jodhpur, Rajasthan, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Chinmayee Choudhury
bDepartment of Experimental Medicine and Biotechnology, Post Graduate Institute of Medical Education and Research, Chandigarh., India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Purvi Purohit
aAll India Institute of Medical Sciences, Jodhpur, Rajasthan, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shailendra Dwivedi
cAll India Institute of Medical Sciences, Gorakhpur, Uttar Pradesh, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ankit jain
aAll India Institute of Medical Sciences, Jodhpur, Rajasthan, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ankita Chugh
aAll India Institute of Medical Sciences, Jodhpur, Rajasthan, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Poonam Elhence
aAll India Institute of Medical Sciences, Jodhpur, Rajasthan, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Puneet Pareek
aAll India Institute of Medical Sciences, Jodhpur, Rajasthan, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sanjeev Misra
aAll India Institute of Medical Sciences, Jodhpur, Rajasthan, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Praveen Sharma
aAll India Institute of Medical Sciences, Jodhpur, Rajasthan, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: praveensharma55@gmail.com
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

ABSTRACT

Oral Squamous Cell Carcinoma (OSCC) is common preventable disease when diagnosed early, but mostly its progression follows transition from oral potentially malignant disorders (OPMDs) like Oral Submucous Fibrosis (OSF). However, it is difficult to predict possibilities of progression in these premalignant lesions hence, identification of molecular biomarkers would have major clinical impact in early diagnosis and better prognosis. In this context microRNA’s(miR’s) provide better opportunities in malignancy prediction and demarcation in OSF to OSCC transition as they perform key regulatory roles in many tumorigenic processes. Here, we computationally screened differentially expressed miR’s of OSCC and OSF from public databases followed by construction of protein interaction networks and enrichment analyses. The relevant miR’s were validated using qPCR of total 93 samplesincluding 34 OSCC, 30 OSF and 29 control blood and tissue samples. We identified significant down regulation of miR-133a-3p in OSCC compared to controls and interesting up-regulation compared to OSCC and control. miR-9-5p was up-regulated in OSF as well as OSCC and down-regulated in OSF compared to OSCC. Therefore, these two miR’s may serve as risk stratification biomarkers with validation in larger categorical datasets.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

AIIMS/RES(04)/2017/224

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Institutional ethical committee

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • SU, JV, AC, AJ, PP, PE, PP and PS thank AIIMS, Jodhpur for financial support and research facilities, SD thank AIIMS, Gorakhpur for financial support, CC thank DST-INSPIRE research grant and Department of Experimental Medicine and Biotechnology, Post Graduate Institute of Medical Education and Research, Chandigarh. SU thank CSIR for financial support in form of CSIR-Senior Research fellowship.

  • The authors declare no conflicts of interest.

  • The figures in pdf were not clear

Data Availability

supplimentary data

  • ABBREVATIONS

    OSCC
    Oral squamous cell carcinoma
    HNSCC
    Head and neck cancer
    OPMDs
    Oral potentially malignant disorders
    OSF
    Oral submucous fibrosis
    EMT
    Epithelial mesenchymal transition
    HPV
    Human papilloma virus
    miR’s
    microRNA’s
  • Copyright 
    The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
    Back to top
    PreviousNext
    Posted October 08, 2020.
    Download PDF

    Supplementary Material

    Data/Code
    Email

    Thank you for your interest in spreading the word about medRxiv.

    NOTE: Your email address is requested solely to identify you as the sender of this article.

    Enter multiple addresses on separate lines or separate them with commas.
    In-silico, interactomic and clinical validation based approach for screening and identification of miR biomarkers involved in Oral submucous fibrosis to Oral squamous cell carcinoma transition
    (Your Name) has forwarded a page to you from medRxiv
    (Your Name) thought you would like to see this page from the medRxiv website.
    CAPTCHA
    This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
    Share
    In-silico, interactomic and clinical validation based approach for screening and identification of miR biomarkers involved in Oral submucous fibrosis to Oral squamous cell carcinoma transition
    Shweta Ukey, Jeewan Ram Vishnoi, Chinmayee Choudhury, Purvi Purohit, Shailendra Dwivedi, Ankit jain, Ankita Chugh, Poonam Elhence, Puneet Pareek, Sanjeev Misra, Praveen Sharma
    medRxiv 2020.10.05.20206904; doi: https://doi.org/10.1101/2020.10.05.20206904
    Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
    Citation Tools
    In-silico, interactomic and clinical validation based approach for screening and identification of miR biomarkers involved in Oral submucous fibrosis to Oral squamous cell carcinoma transition
    Shweta Ukey, Jeewan Ram Vishnoi, Chinmayee Choudhury, Purvi Purohit, Shailendra Dwivedi, Ankit jain, Ankita Chugh, Poonam Elhence, Puneet Pareek, Sanjeev Misra, Praveen Sharma
    medRxiv 2020.10.05.20206904; doi: https://doi.org/10.1101/2020.10.05.20206904

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero
    • Tweet Widget
    • Facebook Like
    • Google Plus One

    Subject Area

    • Oncology
    Subject Areas
    All Articles
    • Addiction Medicine (76)
    • Allergy and Immunology (198)
    • Anesthesia (54)
    • Cardiovascular Medicine (492)
    • Dentistry and Oral Medicine (90)
    • Dermatology (56)
    • Emergency Medicine (169)
    • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (213)
    • Epidemiology (5706)
    • Forensic Medicine (3)
    • Gastroenterology (217)
    • Genetic and Genomic Medicine (870)
    • Geriatric Medicine (88)
    • Health Economics (232)
    • Health Informatics (763)
    • Health Policy (394)
    • Health Systems and Quality Improvement (254)
    • Hematology (105)
    • HIV/AIDS (182)
    • Infectious Diseases (except HIV/AIDS) (6498)
    • Intensive Care and Critical Care Medicine (391)
    • Medical Education (118)
    • Medical Ethics (28)
    • Nephrology (93)
    • Neurology (850)
    • Nursing (44)
    • Nutrition (141)
    • Obstetrics and Gynecology (163)
    • Occupational and Environmental Health (263)
    • Oncology (515)
    • Ophthalmology (163)
    • Orthopedics (44)
    • Otolaryngology (107)
    • Pain Medicine (48)
    • Palliative Medicine (21)
    • Pathology (149)
    • Pediatrics (251)
    • Pharmacology and Therapeutics (147)
    • Primary Care Research (114)
    • Psychiatry and Clinical Psychology (972)
    • Public and Global Health (2237)
    • Radiology and Imaging (377)
    • Rehabilitation Medicine and Physical Therapy (174)
    • Respiratory Medicine (313)
    • Rheumatology (109)
    • Sexual and Reproductive Health (81)
    • Sports Medicine (82)
    • Surgery (118)
    • Toxicology (25)
    • Transplantation (34)
    • Urology (42)